Longitudinal patient-reported outcomes in patients receiving chimeric antigen receptor T-cell therapy
2023 · Blood Advances · 35 citations
https://doi.org/10.1182/bloodadvances.2022009117
R
Richard Newcomb
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
92
Papers
967
Citations
16
h-index
23
i10-index
Richard Newcomb is an academic researcher from Boston Medical Center. The author has contributed to research in topics: Cancer survivorship and care & Childhood Cancer Survivors' Quality of Life & Palliative Care and End-of-Life Issues. The author has an h-index of 16, co-authored 79 publications.
ORCID: 0000-0002-8251-6961Papers by this author
worksClinical Outcomes and Toxicity in Older Adults Receiving Chimeric Antigen Receptor T Cell Therapy
2024 · Transplantation and Cellular Therapy · 20 citations
https://doi.org/10.1016/j.jtct.2024.02.019
A phase 2 multicenter trial of ruxolitinib to treat bronchiolitis obliterans syndrome after allogeneic HCT
2024 · Blood Advances · 12 citations
https://doi.org/10.1182/bloodadvances.2024014000
End-of-Life Care for Older Adults with Aggressive Non-Hodgkin Lymphoma
2021 · Journal of Palliative Medicine · 4 citations
https://doi.org/10.1089/jpm.2021.0228
Multisite Randomized Trial of Inpatient Palliative Care Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation
2025 · Journal of Clinical Oncology · 4 citations
https://doi.org/10.1200/jco-25-00378
A Digital Intervention to Address Sexual Health in Hematopoietic Stem Cell Transplant Survivors
2025 · Journal of the National Comprehensive Cancer Network · 2 citations
https://doi.org/10.6004/jnccn.2024.7076
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat